[1] 钱军,秦叔逵,何泽明,等.三氧化二砷治疗中晚期原发性肝癌的临床研究.中华肝脏病学杂志,2002,10:63. [2] 王振义.开展砷剂治疗白血病的临床机制研究.中华血液学杂志,1996,17:57. [3] Niu C, Yan H, Yu T, et al. Studies on treatment of acute promyeloeytie leukemia with arsenic trioxide:remission induction, follow-up,and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood, 1999, 94:3315-3324. [4] Lallemand-Breitenbach V, Guillemin MC, Janin A, et al. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med, 1999, 189:1043-1052. [5] Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide (As2O3)in the treatment of acute promyeloeytic leukemia (APL):I. As2O3exerts dose-dependent dual effects on APL cells. Blood, 1997 , 89:3345-3353. [6] Grad JM, Bahlis NJ, Reis I, et al. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood,2001, 98:805-813. [7] Chen GQ, Zhu J, Shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PMLRAR alpha/PML proteins. Blood, 1996, 88:1052-1061. [8] 张汝芝,朱文元,汪晨.三氧化二砷诱导Cloundman S91恶性黑素瘤细胞凋亡的研究.临床皮肤科杂志,2003,32:121-123. |